靶向 PIM2 通过促进 CD8 T 细胞的效应功能和持久性增强抗肿瘤免疫 Targeting PIM2 improves antitumor immunity through promoting effector function and persistence of CD8 T cells. PubMed 2026/01/27 发表J Clin InvestQ1 · IF 14.3(JCR 2025) 靶点:CD19技术:CAR-T技术:TCR-T乳腺癌白血病黑色素瘤 77.1分 ★★★★☆ 站内排序·非疗效